Crescita Therapeutics Inc (CTX) — Cash Flow Reinvestment Rate
Crescita Therapeutics Inc (CTX) has a Cash Flow Reinvestment Rate of 1.74x as of December 2025, reinvesting CA$724.00K (capex CA$724.00K ) from operating cash flow of CA$416.00K. Explore CTX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Crescita Therapeutics Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Crescita Therapeutics Inc across 5 annual periods. Also explore Crescita Therapeutics Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Crescita Therapeutics Inc (2019–2025)
Year-by-year capital reinvestment analysis for Crescita Therapeutics Inc. For live market cap and broader valuation context, see Crescita Therapeutics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | CA$333.00K | CA$1.07 Million | CA$333.00K | ▼ -73.6% |
| 2024 | 1.18x | CA$3.20 Million | CA$2.73 Million | CA$1.19 Million | ▲ +817.6% |
| 2023 | 0.13x | CA$266.00K | CA$2.08 Million | CA$133.00K | ▲ +508.9% |
| 2020 | 0.02x | CA$118.00K | CA$5.61 Million | CA$59.00K | ▼ -74.0% |
| 2019 | 0.08x | CA$430.00K | CA$5.31 Million | CA$215.00K | — |